Effect Of Carvedilol Versus Metoprolol On Glycemic Control In Patients With Type II Diabetes And Hypertension
NCT00060931 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 501
Last updated 2015-04-14
Summary
Evaluation of the effect of two different antihypertensive treatments on control of glucose in Type II diabetic patients with high blood pressure
Conditions
Interventions
- DRUG
-
carvedilol
- DRUG
-
metoprolol
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
GSK Clinical Trials · GlaxoSmithKline
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 30 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2001-06-30
- Primary Completion
- 2004-04-30
- Completion
- 2004-04-30
Countries
- United States
Study Locations
More Related Trials
-
The Effect of Metformin on the Correlation Between Hyperinsulinemia and Hypertension
NCT01342614 ·Status: COMPLETED ·Phase: NA
-
GSK189075, GW869682 Or Placebo In Type 2 Diabetic Patients
NCT00291356 ·Status: COMPLETED ·Phase: PHASE2
-
Metformin Hydrochloride Sustained-release Tablets (Ⅲ) in Patients With Type 2 Diabetes Mellitus Complicated With Coronary Heart Disease
NCT06932874 ·Status: RECRUITING ·Phase: PHASE4
-
Study of the Durability of Glycemic Control With Nateglinide
NCT00858013 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison Between Metformin and Glyburide in the Management of Gestational Diabetes
NCT06589141 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Study in Type 2 Diabetic Subjects on Stable Metformin Therapy to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Co-administering Single and Multiple Oral Doses of GSK1292263
NCT01128621 ·Status: COMPLETED ·Phase: PHASE2
-
Dose Comparisons of Leucine-Metformin Combinations on Blood Glucose Levels In Type 2 Diabetic Patients
NCT02151461 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Metformin Treatment on Thyroid Hormone Metabolism in Euthyroid Patients With Type 2 Diabetes Mellitus
NCT00463502 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of Oral Acarbose Treatment in Patients With Type 2 Diabetes Mellitus
NCT01316861 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Mitiglinide vs Acarbose in Patients With Type 2 Diabetes Mellitus
NCT02143765 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans
NCT01762046 ·Status: COMPLETED ·Phase: PHASE1
-
Mitiglinide in Combination With Metformin vs. Metformin Alone in Patients With Type 2 Diabetes Mellitus
NCT00519142 ·Status: COMPLETED ·Phase: PHASE3
-
A Multiple Dose Investigational Drug Study in Patients With Type 2 Diabetes (MK-0941-005)
NCT00511667 ·Status: COMPLETED ·Phase: PHASE1
-
Glyburide and Metformin for Gestational Diabetes Mellitus (GDM)
NCT01329016 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Cardioprotective and Metabolic Effects of Metformin in Patients With Heart Failure and Diabetes
NCT01690091 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Evaluation of Glucose Lowering Effect, Safety and Tolerability of CS-917
NCT00290940 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Test MK-0941 in Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (MK-0941-017)
NCT00792935 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of INCB013739 Plus Metformin Compared to Metformin Alone on Glycemic Control in Type 2 Diabetics
NCT00698230 ·Status: COMPLETED ·Phase: PHASE2
-
Glyburide/Metformin 5 mg/500 mg Film-Coated Tablets, Fed
NCT00835991 ·Status: COMPLETED ·Phase: PHASE1
-
Comparison of Metformin and Repaglinide Monotherapy in the Treatment of New Onset Type 2 Diabetes Mellitus in China
NCT02040246 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Combination of Mitiglinide and Metformin on Glycemic Control in Patients With Type 2 Diabetes Mellitus
NCT01037842 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Liraglutide or Glimepiride Added to Metformin on Blood Glucose Control in Subjects With Type 2 Diabetes
NCT00614120 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Comparison of Cofrogliptin Add-on Versus Metformin Dose-escalation in Type 2 Diabetes Patients Inadequately Controlled With SGLT-2 Inhibitors Plus Low-Dose Metformin:A Multicenter, Open-Label Trial
NCT06863532 ·Status: RECRUITING ·Phase: NA
-
A Study Comparing the Amount of Metformin and After Taking a Combination Tablet vs. Separate Tablets
NCT01055691 ·Status: COMPLETED ·Phase: PHASE1
-
A Pharmacokinetic Study of MK-0941 After Multiple Daily Doses in Subjects With Type 2 Diabetes (MK-0941-012)(COMPLETED)
NCT00873821 ·Status: COMPLETED ·Phase: PHASE1